The chief executive of Irish drugmaker Elan told a newspaper on Monday that he would not block a fresh probe over alleged conflicts of interest at the company.
Elan said on Tuesday it was granted an Irish High Court injunction to stop two non-executive directors from launching a probe over corporate governance at the drugmaker.
It said Jack Schuler and Vaughn Bryson had threatened to take legal action in the Unites States which would have interfered with its own review -- commissioned in May -- the results of which would be presented at the next board meeting on September 15.
Kelly Martin told the Financial Times he would feel fine if the full board were to launch a new inquiry into the claims once it had reviewed the results of the existing audit.
All companies have conflicts, Martin told the paper.
Just because different people are associated with more than one entity doesn't necessarily mean there's a conflict you can't manage through, he said.